Form 8-K - Current report:
SEC Accession No. 0001193125-25-200766
Filing Date
2025-09-11
Accepted
2025-09-11 08:00:18
Documents
14
Period of Report
2025-09-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d45697d8k.htm   iXBRL 8-K 26777
2 EX-99.1 d45697dex991.htm EX-99.1 11052
6 GRAPHIC g45697dsp05.jpg GRAPHIC 4049
  Complete submission text file 0001193125-25-200766.txt   162133

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20250911.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20250911_lab.xml EX-101.LAB 17977
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20250911_pre.xml EX-101.PRE 11251
17 EXTRACTED XBRL INSTANCE DOCUMENT d45697d8k_htm.xml XML 3702
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 251307240
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)